ChemoCentryx
CCXI
#3542
Rank
A$5.35 B
Marketcap
A$74.45
Share price
0.00%
Change (1 day)
20.39%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: A$5.35 Billion

On November 25, 2022 ChemoCentryx had a market cap of A$5.35 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022A$5.49 B56.22%
2021A$3.51 B-36.89%
2020A$5.57 B63.79%
2019A$3.40 B333.76%
2018A$0.78 B111.06%
2017A$0.37 B-24.27%
2016A$0.49 B-0.11%
2015A$0.49 B35.5%
2014A$0.36 B30.24%
2013A$0.27 B-27.26%
2012A$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$833.47 B 15,466.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$216.43 B 3,942.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$556.23 B 10,288.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$282.69 B 5,179.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$38.15 B 612.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$409.31 B 7,544.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$172.29 B 3,117.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$153.14 B 2,760.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$47.64 B 789.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel